EFFECTS OF PITUITARY BETA-ENDORPHIN SECRETAGOGUES ON THE CONCENTRATION OF BETA-ENDORPHIN IN RAT CEREBROSPINAL-FLUID - EVIDENCE FOR A ROLE OF VASOPRESSIN IN THE REGULATION OF BRAIN BETA-ENDORPHIN RELEASE

被引:18
|
作者
BARNA, I [1 ]
SWEEP, CGJ [1 ]
VELDHUIS, HD [1 ]
WIEGANT, VM [1 ]
DEWIED, D [1 ]
机构
[1] STATE UNIV UTRECHT, FAC MED, DEPT PHARMACOL, RUDOLF MAGNUS INST, 3521 GD UTRECHT, NETHERLANDS
关键词
B-Endorphin; Brain; Cerebrospinal fluid; Corticotropin-releasing factor; Isoproterenol; Pituitary; Plasma; Vasopressin;
D O I
10.1159/000125324
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The concentration of P-endorphin-immunoreactivity (bE-IR) in cerebrospinal fluid (CSF) and plasma of rats was determined following intracerebroventricular (ICV) treatment of conscious animals with substances known to stimulate the release of PE and other pro-opiomelanocortin (POMC)-derived peptides at the level of the anteriorand intermediate lobes of the pituitary. The p-adrenoceptor agoinst isoproterenol (ISO) did not influence the concentration of PE-IR in CSF collected 5-60 min after ICV administration of doses ranging from 3 to 30,000 pg/rat. Plasma bE-IR levels, however, were significantly increased 20 min following ICV injection of 30,000 pg ISO. ICV treatment of animals with ovine corticotropin-releasing factor (CRF; 30-30,000 pg/rat) also did not affect CSF levels of bE-IR, whereas CRF in a dose of 30 pg significantly decreased, and in doses of 300-30,000 pg enhanced plasma bFE-IR concentrations as determined by 20 min following treatments. ICV injection of arginine8-vasopressin (AVP) in doses of 10-1,000 pg/rat dose-dependently elevated the bE-IR concentration in CSF without affecting plasma bE-IR levels. This AVP-induced increase in CSF PE-IR was maximal 20-35 min and bE-IR levels had returned to basal 60 min following treatment. The data indicate that AVP and not ISO and CRF is a stimulator of CSF levels of bE-IR. As bE-IR in CSF likely originates from brain POMC neurons, these results suggest the hot vasopressin may be a physiological regulator of brain POMC activity, and may act as a releasing factor for POMC-derived peptides in the brain. © 1990 S. Karger AG, Basel.
引用
收藏
页码:104 / 110
页数:7
相关论文
共 50 条
  • [41] INTRATHECAL BETA-ENDORPHIN
    FOLEY, KM
    INTURRISI, CE
    [J]. LANCET, 1980, 2 (8189): : 317 - 317
  • [42] CEREBROSPINAL-FLUID VASOPRESSIN, OXYTOCIN, SOMATOSTATIN, AND BETA-ENDORPHIN IN ALZHEIMERS-DISEASE
    RASKIND, MA
    PESKIND, ER
    LAMPE, TH
    RISSE, SC
    TABORSKY, GJ
    DORSA, D
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1986, 43 (04) : 382 - 388
  • [43] DIFFERENCES IN CENTRAL EFFECTS OF BETA-ENDORPHIN AND ENKEPHALINS - BETA-ENDORPHIN A POTENT PSYCHOMOTOR STIMULANT
    BELESLIN, DB
    SAMARDZIC, R
    KRSTIC, SK
    MICIC, D
    [J]. NEUROPHARMACOLOGY, 1982, 21 (01) : 99 - 102
  • [44] FUNCTIONS OF BETA-ENDORPHIN AND ENKEPHALINS IN THE PITUITARY
    ROSSIER, J
    [J]. FRONTIERS IN NEUROENDOCRINOLOGY, 1982, 7 : 191 - 209
  • [45] CEREBROSPINAL-FLUID BETA-ENDORPHIN LEVELS AND CONGENITAL INSENSITIVITY TO PAIN
    DEHEN, H
    AMSALLEM, B
    COLASLINHART, N
    CAMBIER, J
    [J]. REVUE NEUROLOGIQUE, 1986, 142 (05) : 541 - 544
  • [46] BETA-ENDORPHIN AND SCHIZOPHRENIA
    BERGER, PA
    WATSON, SJ
    AKIL, H
    ELLIOTT, GR
    RUBIN, RT
    PFEFFERBAUM, A
    DAVIS, KL
    BARCHAS, JD
    LI, CH
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1980, 37 (06) : 635 - 640
  • [47] BETA-ENDORPHIN AND PARTURITION
    FLETCHER, JE
    THOMAS, TA
    HILL, RG
    [J]. LANCET, 1980, 1 (8163): : 310 - 310
  • [48] BETA-ENDORPHIN IN PREGNANCY
    GOEBELSMANN, U
    ABBOUD, TK
    HOFFMAN, DI
    HUNG, TT
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1984, 17 (2-3) : 77 - 89
  • [49] PERSISTENCE OF BETA-ENDORPHIN IN HUMAN CEREBROSPINAL-FLUID AFTER HYPOPHYSECTOMY
    SCHLACHTER, LB
    WARDLAW, SL
    TINDALL, GT
    FRANTZ, AG
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (01): : 221 - 224
  • [50] BETA-ENDORPHIN IN HUMAN CEREBROSPINAL-FLUID AFTER TOTAL HYPOPHYSECTOMY
    WARDLAW, SL
    SCHLACHTER, LB
    TINDALL, GT
    FRANTZ, AG
    [J]. CLINICAL RESEARCH, 1982, 30 (02): : A278 - A278